• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Valeo Pharma Appoints President, COO

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Cognate BioServices Announces Major Expansion

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Drug Development For Startups

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    Virtual Clinical Trials: The Future of Dermatology Studies
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Flow Sciences

    Syngene

    PCI Pharma Services

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Baxter BioPharma Solutions

    Alcami

    PCI Pharma Services

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Four Pillars to Guide Your CRO Search

    Tips on how to seek out the best possible CRO-Sponsor relationship

    Related CONTENT
    • Trial Runners
    • Mogene
    • SGS Life Sciences
    • Preparing to Adopt Intelligent Label Management
    • Solving the Pharma Talent Crunch
    Alan Findlater , WIL Research11.17.15
    As with many industries, there has been a great deal of change in the contract research space since our company was founded 40 years ago. In the past, large pharmaceutical companies chartered their own path through small molecule development, with dedicated internal R&D teams around the world. That environment has changed and in just the last few years our field has skyrocketed, as businesses look to streamline activities, FDA regulations tighten, and drug development becomes ever more complex.

    Many small to mid-sized companies now embark upon an outsourcing journey with a range of expectations and priorities that aren’t met by their CRO partner. Similarly, large pharmaceutical companies may run into roadblocks, before finding a long-term fit.

    Equipment and facilities are important, but it’s often the intangible qualities that determine a project’s success. Below, we offer some tips on how to seek out the best possible CRO-Sponsor relationship. It’s not a mathematical equation; it’s about finding a cultural, resource-efficient match. Along the way, we hope to help you avoid some common industry hazards.

    First Engagement
    How do you find a hands-on and conscientious partner? Start by talking to your peers (or colleagues with outside experience), to determine which companies have a solid reputation. When you approach those candidates begin screening based on these important qualities:
    • High scientific involvement. From day one you need to have the buy-in of a CRO’s leading scientists. At the end of the day, they are the ones that will be executing your projects. If a company truly values your work, experts at various levels will be made available, including the study director as you finalize negotiations.
    • Customization. You’re not buying an off-the-shelf product, so look for a company that is prepared to listen and adapt to your study needs.
    • Communication. It’s an important customer service measure. How open is the dialogue with your team? Equally important is internal cohesion and integration. How well do the different divisions/experts on their side communicate and share protocol and best practices? Many minds are greater than one.
    • Geography. Related to communication, is the issue of location. CRO industries in regions such as China and India remain strong, but may involve a number of communication barriers. This may not be an issue for your team if the project is routine and well understood on your side. If there are potential variables or unknowns, think about the accessibility of the CRO provider throughout—do they have facilities in different regions and are their personnel near you?
    Finally, ask how the company deals with unforeseen challenges. Are you going to get a mayday call, or a proactive heads up? Ideally the CRO’s various experts will come together to troubleshoot on your behalf.

    Bigger Isn’t Always Better
    Companies look to a CRO for their specialization. But the meaning of that goes far beyond types of studies or molecules. Many large CROs have evolved to deal with high volumes of repetitive, clearly prescribed work from large pharmaceutical companies. That’s great if you have a defined project. If you’re a smaller company however, that service may have specialized away from your core needs.

    To find the right fit, ask yourself whether the transaction is about capital and resources, or co-opting expertise and a holistic service.

    ‘Classic’ large pharmaceutical projects typically involve:
    • High volumes
    • Pre-prepared study designs
    • A hands-off approach
    • The sponsor has staff and expertise in place to handle the results
    Does this model resonate? Or would you benefit from:
    • Protocol and study design
    • Project advice and customization
    • Ongoing communication and troubleshooting
    • Training and resource advice
    • An extra set of eyes, to ensure all regulatory standards are met
    One further consideration in this space is how well both teams’ resources will be utilized. Is your small study being run on high-throughput equipment? If so, are you paying for the high capacity potential? It’s all relative and may change if your process scales.
    Finally, determine if that end-stage chain link is strong – the one that translates a CROs findings into actionable data for your team. What sort of results are you going to be passed? Is there necessary support in place if you are small company that requires bioinformatics, medical writing or data management advice?

    The Study Director is Key
    The study director is arguably the most important person in your CRO-sponsor relationship. Behind all successfully outsourced projects are talented and conscientious leaders. Once again, finding a suitable cultural fit is important. They also need to be involved from the beginning, so you can assess them and they can get a running start.

    In the modern CRO landscape, consistently achieving aggressive regulatory submission milestones with complex programs of work has become the norm rather than the exception. The interdisciplinary scientific coordination this requires has created new opportunities and challenges for the study director role. For success, they have had to advance their drug development savvy and cross-functional know-how.

    Study directors are the key link between client and CRO. They are also viewed as the scientific focal point for regulatory authorities and are responsible for delivering study results that meet stringent GLP standards. To do so, they need to be ‘get it done’ leaders who are effective at managing personnel, timelines, study design, protocol and delivery of results. Above all they need to be effective project managers and communicators.

    Interdisciplinary Programs – ‘Co-ordination Competence’
    Outsourcing programs of work has added new challenges to managing CRO partners. Client expectations have risen considerably as they aggressively target submission deadlines for their precious development assets. While in the past, work was outsourced on a study-by-study basis, in today’s R&D environment companies increasingly look for complete programs of work, targeting a specific regulatory deadline. Some examples include investigational new drug (IND) enabling packages, or even complete development packages that incorporate chronic toxicity studies.

    You may be attracted to a CRO for their established expertise in toxicology, ADME or bioanalytical chemistry. But, chances are, you’ll have a diverse set of needs throughout your research and development pipeline. Keenly investigate how these needs are going to be coordinated by the CRO and ask what mechanisms they have in place to ensure reliable achievement of interdisciplinary project plan milestones. The collaboration component of study directors (both scientifically and logistically) within an overall program is now essential to satisfy client needs.

    Such programs are only as good as their weakest link. It is therefore highly important to probe for study director fit for each of the disciplines in the package. Also be sure to pressure test the CRO’s ‘coordination competencies.’ The core ability of a CRO to integrate multidisciplinary scientific workstreams into a coherent program delivered to tight submission deadlines has become the real benchmark of a competent CRO partner.

    Of course, it takes two to tango! Achieving complex on-time deliverables requires both parties to be working closely together with joint ownership of program goals. Your chosen CRO partner must become an extension of your team, far away from the traditional supplier/customer paradigm. This can only be achieved by finding a true sense of ownership in the CRO mindset. Look for a CRO that demonstrates empathy at all levels, with evidence that shows your project will become their project and not a simply a set of tasks to perform. Finally, don’t hesitate to devote time to visit CRO sites and be exposed to as many staff at possible. By doing so, you’ll develop a clearer picture of a CRO’s key people and the values that they will bring to your outsourced project. 


    Alan Findlater is chief commercial officer at WIL Research.
    Related Searches
    • china
    • CRO
    • Contract Research
    • collaboration
    Suggested For You
    Trial Runners Trial Runners
    Mogene Mogene
    SGS Life Sciences SGS Life Sciences
    Preparing to Adopt Intelligent Label Management Preparing to Adopt Intelligent Label Management
    Solving the Pharma Talent Crunch Solving the Pharma Talent Crunch
    Akebia Therapeutics Names CMO  Akebia Therapeutics Names CMO
    Recro Gainesville Expands Mfg. Capabilities Recro Gainesville Expands Mfg. Capabilities
    Diverse Products And Technologies Delivered Diverse Products And Technologies Delivered
    CROS NT Expands Medidata Pact CROS NT Expands Medidata Pact
    PPD Expands Vaccine Development Lab PPD Expands Vaccine Development Lab
    Dow Offers New Technology to Solve Pharma Challenges Dow Offers New Technology to Solve Pharma Challenges
    UPM Celebrates 100-Years of Mfg. at Tennessee Site UPM Celebrates 100-Years of Mfg. at Tennessee Site
    Catalent Biologics Collaborates with Therachon Catalent Biologics Collaborates with Therachon
    Porton USA Acquires J-STAR Research for $26M Porton USA Acquires J-STAR Research for $26M
    Navigating the Shifting Landscape of Contract API Manufacturing Navigating the Shifting Landscape of Contract API Manufacturing

    Related Features

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    • Drug Development | Drug Discovery | R&D
      R&D Outsourcing Trends

      R&D Outsourcing Trends

      Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
      Kristin Brooks, Managing Editor, Contract Pharma 10.14.20

    • Drug Development | Preclinical Outsourcing
      Preclinical Planning for Successful Drug Development

      Preclinical Planning for Successful Drug Development

      When the preclinical pressure is on, appropriate planning can make sure timelines are achievable.
      Mingyi Trimble, WuXi AppTec 09.09.20


    • APIs | Drug Development | Risk Management
      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-Molecule Drug Development: Advantages of an Integrated, Phase-Based Approach

      Small-molecule drug development has become more complex and challenging, leading to greater reliance on CDMOs.
      Sarah Bethune, Cambrex 09.09.20

    • Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
      Expediting a COVID-19 Vaccine: FDA Approval Process

      Expediting a COVID-19 Vaccine: FDA Approval Process

      The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.
      Kristin Brooks, Managing Editor 09.09.20

    • Chemistry
      Greener by Design

      Greener by Design

      How new approaches to green chemistry are driving sustainable processes.
      Kenneth Ball, Commercial Operations Lead, Pfizer CentreOne 03.04.20


    • Drug Development | Regulatory Affairs
      Guidelines in Toxicology: A Blessing and a Curse

      Guidelines in Toxicology: A Blessing and a Curse

      A look at the evolution of drug development regulatory guides.
      Sarah Gould, Senior Principal Scientific Advisor, Charles River 09.16.19

    • Drug Development
      Flex Your Outsourcing Model to Maximize Drug Development

      Flex Your Outsourcing Model to Maximize Drug Development

      How to choose—and optimize—combinations of service models to fit your needs.
      Timothy King, Executive Director, Functional Service Partnerships (FSP), PPD 09.16.19

    • Biologics, Proteins, Vaccines | Drug Delivery | Drug Development
      Knowledge Sharing: Biologics Development and Delivery

      Knowledge Sharing: Biologics Development and Delivery

      The increasing importance of sharing information to build awareness and better manage the complexities of drug development.
      Fran L. DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services 09.16.19


    • Drug Development
      Improving Your Development Program

      Improving Your Development Program

      Seven lab science trends driving the future of drug development.
      Jenifer Vija, Liam Moran, Chris Loosbroock and Eric Snyder, Charles River 05.07.19

    • Drug Development
      Technical Advantages of Continuous Flow Chemical Synthesis

      Technical Advantages of Continuous Flow Chemical Synthesis

      Continuous flow chemistry is known for its ability to handle hazardous reactions safely, but can also unlock many other technological benefits.
      Shawn Conway, Engineering R&D Director, Cambrex High Point 04.05.19

    • Drug Development | Preclinical Outsourcing
      Early Development Trends

      Early Development Trends

      Catalent’s president of oral drug delivery, Jonathan Arnold, talks trends and challenges in the early phases of drug development.
      Tim Wright, Editor, Contract Pharma 03.06.19


    • Drug Development
      Future Trends in the CDMO Space

      Future Trends in the CDMO Space

      And how to navigate them for successful drug development
      Guillaume Plane, Global Development and Marketing Manager, BioReliance End-to-End Solutions, MilliporeSigma 01.25.19

    • APIs | Cytotoxics and High Potency Manufacturing | Drug Development
      CDMOs On The Rise

      CDMOs On The Rise

      Tracking growth and strategies in the CDMO business
      Michel Le Bars, Managing Partner, Kurmann Partners AGe 01.25.19

    • Drug Development | Formulation Development
      Abuse Deterrent Formulations

      Abuse Deterrent Formulations

      A look at opioid abuse in North America and formulations to help avoid an epidemic.
      Damon Smith, Richard Dart and Christopher Hirst 11.13.18

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Virtual Clinical Trials: The Future Of Dermatology Studies
    • Sanofi Unveils EUROAPI As Name Of New European API Company
    Breaking News
    • Valeo Pharma Appoints President, COO
    • Metrion, LifeArc Extend Neuroscience Alliance
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Janssen, TenNor Enter NTM Research Pact
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FineHeart Successfully Tests Wireless TET System
    Apria Healthcare Settles Whistleblower Lawsuit
    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valeo Pharma Appoints President, COO
    Metrion, LifeArc Extend Neuroscience Alliance
    Grifols Begins COVID-19 Plasma Treatment Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Redken Unveils Acidic Bonding Concentrate Range
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Manscaped Expands Further in Europe
    Color Street Gives Back
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Super Strong Inks Survive Tough Environments
    Ontex Honored for Mask Production
    TFP Acquires PV3 Technologies
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login